Dr. Reddy’s shines on receiving EIR from USFDA for Srikakulam Plant

21 Sep 2017 Evaluate

Dr. Reddy's Laboratories is currently trading at Rs. 2426.60, up by 113.00 points or 4.88% from its previous closing of Rs. 2313.60 on the BSE.

The scrip opened at Rs. 2336.00 and has touched a high and low of Rs. 2466.40 and Rs. 2336.00 respectively. So far 129339 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3394.95 on 28-Oct-2016 and a 52 week low of Rs. 1901.65 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 2466.40 and Rs. 2179.10 respectively. The current market cap of the company is Rs. 39855.42 crore.

The promoters holding in the company stood at 26.78%, while Institutions and Non-Institutions held 43.38% and 13.68% respectively.

Dr. Reddy’s Laboratories has received an Establishment Inspection Report (EIR) for its Formulation Srikakulam Plant (SEZ) Unit II, Andhra Pradesh from the US Food and Drug Administration (USFDA).

Recently, USFDA had completed the inspection at Dr. Reddy’s API Mirfield Plant, United Kingdom on September 15, 2017. The company had been issued a Form 483 with three observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1268.20 17.10 (1.37%)
11-Dec-2025 11:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1796.00
Dr. Reddys Lab 1268.20
Cipla 1501.55
Zydus Lifesciences 922.85
Lupin 2073.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×